FDA Inspection
New York Blood Center EnterprisesNew York Blood Center Enterprises – FDA Inspection, Nov 22, 2016
Record Details
This FDA Inspection record concerns New York Blood Center Enterprises, with an inspection on November 22, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 95633295-7d18-4ad4-bb57-ad95d23b6ac9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 997377
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of New York Blood Center Enterprises
6| Date | Classification | Office | Project area |
|---|---|---|---|
| July 8, 2026 | Not classified | New York District Office | Blood and Blood Products |
| October 27, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 25, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 29, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 1, 2011 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for New York Blood Center Enterprises
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.